Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 2
1964 1
1965 1
1966 2
1967 1
1969 2
1970 1
1973 1
1976 1
1978 1
1979 1
1980 3
1981 2
1982 2
1983 1
1984 1
1985 7
1987 1
1988 2
1989 3
1990 1
1991 2
1993 1
1995 3
1996 4
1997 2
1998 1
1999 3
2000 1
2001 1
2002 2
2003 3
2004 3
2005 7
2006 13
2007 4
2008 17
2009 13
2010 13
2011 12
2012 15
2013 19
2014 12
2015 17
2016 26
2017 23
2018 28
2019 33
2020 36
2021 49
2022 42
2023 41
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Diabetes Mellitus.
Kanter JE, Bornfeldt KE. Kanter JE, et al. Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1049-53. doi: 10.1161/ATVBAHA.116.307302. Arterioscler Thromb Vasc Biol. 2016. PMID: 27225786 Free PMC article. Review. No abstract available.
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ Jr, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF. Kanter J, et al. N Engl J Med. 2022 Feb 17;386(7):617-628. doi: 10.1056/NEJMoa2117175. Epub 2021 Dec 12. N Engl J Med. 2022. PMID: 34898139 Clinical Trial.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. Among authors: kanter j. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Ataga KI, et al. Among authors: kanter j. N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3. N Engl J Med. 2017. PMID: 27959701 Free PMC article. Clinical Trial.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: kanter j. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
Pressors and inotropes.
Kanter J, DeBlieux P. Kanter J, et al. Emerg Med Clin North Am. 2014 Nov;32(4):823-34. doi: 10.1016/j.emc.2014.07.006. Epub 2014 Aug 28. Emerg Med Clin North Am. 2014. PMID: 25441037 Review.
Dr. Djunga: First Congolese Neurosurgeon.
Tshimbombu TN, Song SH, Kanter JH. Tshimbombu TN, et al. Among authors: kanter jh. World Neurosurg. 2022 Apr;160:68-70. doi: 10.1016/j.wneu.2022.01.106. Epub 2022 Jan 29. World Neurosurg. 2022. PMID: 35101612 Review.
436 results